3.8 Article

Clinical characteristics and treatment outcomes of patients with newly diagnosed schizophrenia: A 4-year single-center experience in Saudi Arabia

Journal

NEUROPSYCHOPHARMACOLOGY REPORTS
Volume 42, Issue 2, Pages 199-204

Publisher

WILEY
DOI: 10.1002/npr2.12247

Keywords

antipsychotic drugs; newly diagnosed; outcomes; schizophrenia

Funding

  1. Substance Abuse Research Center (SARC), through the Deanship of Scientific Research, Jazan University, Jazan, Saudi Arabia

Ask authors/readers for more resources

Understanding how local psychiatry clinic characteristics shape research findings is crucial for applying research into mental health evolution, outcomes, and costs. This study reviewed data from a psychiatry clinic in Saudi Arabia and found substantial individual variations in characteristics and response to initial antipsychotic medication.
Objectives Understanding how local psychiatry clinic characteristics shape research findings is essential for applying research into evolution, outcomes, and costs of mental health. However, a paucity of psychiatry clinics details has implications for the interpretation and utilization of this research. Methods We reviewed data of 746 patients with new-onset schizophrenia on antipsychotic monotherapy seen over four years in an adult psychiatry clinic at Jazan Health, Saudi Arabia. Protocol-driven interviews and investigations were recorded prospectively and extracted from the medical records for the study. Summary statistics and logistic regression analyses were applied to assess patients' characteristics and outcomes. Results The median patient age was 32 (IQR 27-39) years. Of patients, 589 (79.0%) were male, and 679 (91.0%) had a low-level education. The median follow-up duration was 51.4 (IQR 27.4-96.3) weeks. The most used initial antipsychotic drugs were olanzapine (48.8%), haloperidol (13.9%), and aripiprazole (11.3%). The numbers of patients who retained the initial drug at 24 and 52 weeks were 539 (72.3%) and 325 (43.6%), respectively. The initial drug was changed in 246 (33.0%) patients. The median time to initial drug change was 43.9 (IQR 14.8-85.0) weeks. The logistic regression demonstrated that male sex (P < 0.004), young adult age group (P < 0.027), predominant positive symptoms (P < 0.021), treatment with haloperidol (P < 0.024), and khat use (P < 0.006) were significant factors for drug change. Conclusions This clinical records study demonstrated substantial individual variations in characteristics and in responding to initial antipsychotic medication. Insight into these findings will facilitate the planning for comprehensive research programs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available